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Crystal structures of substrate binding to Bacillus subtilis 
holo-(acyl carrier protein) synthase reveal a novel trimeric
arrangement of molecules resulting in three active sites
Kevin D Parris1*†, Laura Lin1†, Amy Tam1, Rebecca Mathew1, Jeffrey Hixon2,
Mark Stahl1, Christian C Fritz2, Jasbir Seehra1 and William S Somers1*
Background: Holo-(acyl carrier protein) synthase (AcpS), a member of the
phosphopantetheinyl transferase superfamily, plays a crucial role in the functional
activation of acyl carrier protein (ACP) in the fatty acid biosynthesis pathway.
AcpS catalyzes the attachment of the 4′-phosphopantetheinyl moiety of
coenzyme A (CoA) to the sidechain of a conserved serine residue on apo-ACP. 
Results: We describe here the first crystal structure of a type II ACP from
Bacillus subtilis in complex with its activator AcpS at 2.3 Å. We also have
determined the structures of AcpS alone (at 1.8 Å) and AcpS in complex with
CoA (at 1.5 Å). These structures reveal that AcpS exists as a trimer. A catalytic
center is located at each of the solvent-exposed interfaces between AcpS
molecules. Site-directed mutagenesis studies confirm the importance of trimer
formation in AcpS activity. 
Conclusions: The active site in AcpS is only formed when two AcpS
molecules dimerize. The addition of a third molecule allows for the formation
of two additional active sites and also permits a large hydrophobic surface
from each molecule of AcpS to be buried in the trimer. The mutations
Ile5→Arg, Gln113→Glu and Gln113→Arg show that AcpS is inactive when
unable to form a trimer. The co-crystal structures of AcpS–CoA and
AcpS–ACP allow us to propose a catalytic mechanism for this class of 
4′-phosphopantetheinyl transferases.
Introduction
Acyl carrier proteins (ACPs) play important roles in a
number of biosynthetic pathways that are dependent
upon acyl group transfers [1]. ACPs are predominately
associated with the biosynthesis of fatty acids [2,3] but
are also utilized in the synthesis of polyketide antibiotics
[4,5], non-ribosomal peptides [6,7], and intermediates
used in the synthesis of vitamins, such as the protein-
bound coenzymes lipoic acid [8] and biotin [9]. The ACP
in each of these pathways is composed of 80–100 residues
and is either an integrated domain in a larger multifunc-
tional protein (type I) or is a structurally independent
protein that is part of a non-aggregated multienzyme
system (type II). Type I ACPs are found in mammals,
fungi and certain mycobacteria, whereas type II ACPs are
utilized by plants and most bacteria. The Escherichia coli
ACP for fatty acid synthesis has been over-expressed
[10], purified [11,12], and the low-resolution solution
structure solved using nuclear magnetic resonance
(NMR) spectroscopy [13]. The fact that these proteins
are essential for the maturation of the organism has led to
their investigation as targets for the development of new
antimicrobial agents [14–18]. 
ACPs require post-translational modification for activity.
They are converted from an inactive apo form to an active
holo form by the transfer of the 4′-phosphopantetheinyl
(P-pant) moiety of coenzyme A (CoA) to a conserved
serine on the ACP. The β-hydroxyl sidechain of the serine
residue serves as a nucleophilic group attacking the
pyrophosphate linkage of CoA. Evidence suggests that
each synthase that is dependent upon P-pant attachment
for activation has its own partner enzyme responsible for
this attachment [19].
The post-translational modification of the ACP subunit in
the fatty acid synthase is performed by holo-(acyl carrier
protein) synthase (AcpS; EC 2.7.8.7). One of the best-char-
acterized members of the P-pant transferase family is the
E. coli AcpS [20]. This enzyme produces holo-ACP by
transferring the P-pant moiety from CoA to Ser36 of the
E. coli apo-ACP in a magnesium-dependent reaction [20].
The over-expression and purification of the E. coli AcpS
has been described [21] and this protein has been classi-
fied as a member of a new enzyme superfamily, the phos-
phopantetheinyl transferases [19]. The P-pant transferase
superfamily can be roughly divided into two subgroups
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[22]. Enzymes responsible for modifying the peptidyl
carrier protein subunits of non-ribosomal peptide syn-
thetases are good examples for the first subgroup, which
are usually ~230 amino acids in size. The crystal structure
of one member of this enzyme subgroup, the surfactin syn-
thetase activating enzyme Sfp, has been solved recently;
the structure has twofold intramolecular pseudosymmetry
with the CoA-binding site at the interface of the symmetri-
cal fold [22]. AcpS and other enzymes transferring the P-
pant group onto domains of the fatty acid synthases are
usually smaller, in the order of 120 residues, and belong to
the second subgroup of the P-pant transferase superfamily.
The sequence homology between these two subgroups is
rather low (between 12 and 22%). Alignment [19–22] of
these proteins shows that two regions, residues 5–13 and
54–65 (E. coli AcpS numbering), are highly conserved.
Here we report the X-ray crystal structures of Bacillus sub-
tilis AcpS both with (at 1.5 Å) and without (at 1.8 Å)
bound CoA. Furthermore, we report the structure of AcpS
in complex with holo-ACP at 2.3 Å. These structures are
the first from the AcpS subfamily of P-pant transferases
and the structure of holo-ACP is the first X-ray structure
of an ACP. Examination of these structures reveal that
each AcpS adopts a fold similar to half of the Sfp molecule
with, at a cursory glance, the oligomeric state being the
most significant difference between AcpS and Sfp. It has
been speculated that the active form of AcpS is a dimer
[21,22], but our results show that AcpS forms a trimer that
contains three active sites. In this family of enzymes the
active site is highly conserved, therefore, the structures
detailed here will assist in the design of broad-spectrum
antibiotics. Additionally, these structures demonstrate the
nature of ACP and CoA binding as well as providing
insights into the mechanism of P-pant transfer.
Results and discussion
Structure determination
The crystal structure of AcpS was solved using multiwave-
length anomalous diffraction (MAD) with a selenomethio-
nine (SeMet) derivative [23]. Experimental phases were
determined at 2.5 Å, modified by solvent-flattening, non-
crystallographic symmetry averaging and extended to
2.2 Å. Figure 1 shows that the resulting experimental map
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Figure 1
Electron-density maps. (a) Experimental map
generated with MAD phases, obtained from
scattering of selenium in the P21 form of
AcpS, superimposed on the refined
coordinates. (b) The final refined 2Fo–Fc map
contoured at 1σ for the same region shown in
(a). In both (a) and (b), it is clear that the
β-phosphate has trigonal bi-pyramidal
characteristics. In addition to the labeled
residues, the calcium is shown as a light blue
sphere and the waters completing the
coordination sphere are in dark blue. The
figure was generated with Ribbons [41].
was of high quality. The final model was refined to a crys-
tallographic R factor of 19.6% and an Rfree of 21.9%
(Tables 1 and 2). Incubating the protein with CoA prior to
crystallization generated the complex between AcpS and
CoA. The structure of this complex was solved using a
combination of molecular replacement and MAD phasing.
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Table 1
Statistics for data collection and phase determination.
AcpS MAD AcpS–CoA MAD AcpS AcpS–CoA AcpS–ACP
Remote Peak Inflection Remote Peak Inflection Native Native Native
Wavelength (Å) λ3 = 0.93 λ1 = 0.97853 λ2 = 0.97860 λ3 = 0.93 λ1 = 0.97836 λ2 = 0.97858 λ = 1.2 λ = 1.2 λ = 1.54
Resolution range (Å) 15–2.4 15–2.5 15–2.4 15–1.9 15–1.9 15–1.9 20–1.8 100–1.5 15–2.3
Rmerge* (%) 8.0 (25.8) 6.8 (15.5) 7.8 (29.4) 6.0 (36.1) 5.9 (21.4) 5.7 (20.5) 7.6 (46.8) 6.4 (30.7) 5.7 (56.0)
Completeness (%) 100 (100) 100 (100) 100 (100) 99.9 (100) 99.9 (100) 99.6 (100) 96.4 (68.6) 99.9 (98.9) 97.7 (94.5)
Total reflections 239,608 261,205 249,873 62,649 60,726 56,988 31,4385 64,434 27,0151 
Unique reflections 38,299 33,941 38,335 8174 6982 7031 87,902 17,170 29,694
I/σ(I) 26.1 (7.03) 31.9 (12.7) 28.4 (8.1) 33.2 (13.1) 36.9 (16.9) 35.8 (16.7) 15.1 (1.9) 18.1 (4.0) 26.6 (3.5)
f′(e–)† –2.18 –7.35 –9.5 –2.18 –7.35 –9.52
f′′(e–) 3.46 5.92 3.15 3.46 5.92 3.15
MAD phasing: AcpS
Resolution limits (Å) 6.46 4.8 3.99 3.49 3.13 2.87 2.67 2.5 Overall
Phasing power‡
λ3 anomalous 2.88 2.01 1.39 1.03 0.8 0.59 0.46 0.35 0.93
λ1 isomorphous 0.003 0.003 0.003 0.003 0.003 1.86 1.48 1.2 0.003
λ1 anomalous 3.85 3.10 2.09 1.59 1.29 1.01 0.80 0.64 1.45
λ2 isomorphous 6.96 5.15 3.34 2.54 2.03 1.64 1.25 0.03 2.19
λ2 anomalous 2.37 1.81 1.28 1.00 0.77 0.60 0.46 0.01 0.80
Mean FOM§ 0.77 0.71 0.58 0.48 0.39 0.29 0.21 0.15 0.38
MAD phasing: AcpS–CoA
Resolution limits (Å) 6.73 4.41 3.50 2.99 2.64 2.40 2.21 2.06 Overall
Phasing power
λ3 anomalous 3.50 2.50 1.99 1.83 1.42 1.14 0.83 0.66 1.42
λ1 isomorphous 1.57 1.22 1.11 1.16 1.12 1.11 1.01 0.92 1.10
λ1 anomalous 4.54 3.42 2.87 2.64 2.11 1.61 1.22 0.97 2.04
λ2 isomorphous 1.53 1.00 0.67 0.53 0.45 0.36 0.37 0.24 0.51
λ2 anomalous 2.81 2.29 1.98 1.70 1.40 1.14 0.85 0.68 1.37
Mean FOM 0.62 0.51 0.51 0.50 0.44 0.38 0.28 0.12 0.38
*Rmerge = Σ|Ih – <Ih>|/ΣIh, where <Ih> is the average intensity over
symmetry equivalents. Numbers in parentheses reflect statistics for the
last shell. †f′ and f′′ reported values were refined by SHARP. ‡Phasing
power = Σ|FH|/Σ|||FPHobs| – |FPHcalc||, where FH is the calculated heavy-
atom structure-factor amplitude. §Figure of merit = <ΣP(α)eiα/Σ|P(α)|>,
where α is the phase and P(α) is the phase probability distribution.
Table 2
Refinement statistics.
Model refinement AcpS AcpS–CoA AcpS–ACP
Maximum resolution (Å) 1.8 1.5 2.3
Rwork (%)* 19.6 18.6 22.2
Rfree (%)† 21.9 20.1 27.9
<B value> (Å3) 30.6 17.5 52.3
Rms deviations from ideal geometry
bonds (Å) 0.007 0.008 0.015
angles (°) 1.34 1.31 1.8
B values (Å2) 2.18 2.19 2.05
Non-hydrogen protein atoms 6972 1147 6972
Water molecules 471 99 125
Ions 8 Sodium, 19 chlorine 2 Calcium 1 Sodium
Other molecules 5 DTT, 2 glycerol 1 CoA None
*Rwork = Σ||Fobs| – |Fcalc|/Σ|Fobs|. †Rfree is equivalent to Rwork, but calculated for a randomly chosen 5% (or 10%) of reflections omitted from the
refinement process. 
The final model was refined to a crystallographic R factor
of 18.6% and an Rfree of 20.1%. The AcpS protein that was
used for crystallizing both the native and CoA complex
was recombinant full-length AcpS containing an N-termi-
nal His6-tag with a glycine spacer. This protein also had a
mutation at residue 96, where glutamine was replaced
with proline, presumably as a result of an error in the poly-
merase chain reaction. The activity of this mutant is indis-
tinguishable from the wild-type in its P-pant transferase
activity (data not shown).
The structure of the complex between AcpS and holo-
ACP was solved with molecular replacement using
AMoRe [24] with AcpS from the AcpS–CoA structure as
the probe. The final model was refined to a crystallo-
graphic R factor of 22.2% and an Rfree of 27.9%. Holo-ACP
was used for the crystallization of this complex and this
ACP construct had five additional residues at the N termi-
nus that were a remnant of the protease cleavage site from
the glutathione-S-transferase (GST)–ACP fusion protein.
The AcpS construct used in obtaining this structure began
at residue 2 and did not contain a His6-tag.
Despite numerous attempts, we were unable to obtain
diffraction-quality crystals of the ACP–AcpS complex
with the His6-tagged construct of AcpS used for the
native and CoA structures. As a result, we investigated
different forms of the protein which ultimately led to the
construct used in this co-structure with ACP. This con-
struct of AcpS was a recombinant non-His-tagged protein
in which residue 2 was changed from isoleucine to alanine
to accommodate a restriction site during plasmid con-
struction. Consequently, the N-terminal initiation
methionine was removed during expression in E. coli in
accordance with the known substrate specificity of E. coli
methionylaminopeptidase [25]. We were surprised that
the activities of these two enzyme constructs were very
different but, as we will show, the crystal structures help
us interpret this result.
The structure of AcpS
The final model of AcpS contains six copies of the protein
arranged as two groups of three (Figure 2). Each copy con-
sists of at least residues 1–118 (Figure 3). Also present in the
asymmetric unit are 471 solvent molecules, eight sodium
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Figure 2
AcpS–CoA interactions. (a) Ribbon diagram
showing CoA bound in each active site of the
AcpS trimer. Also shown in the center of the
trimer are the three amino acids chosen for
mutagenesis studies: Ile2 (red), Ile5 (brown),
Gln113 (blue). This trimeric arrangement of
AcpS molecules is observed in all three
structures presented in this paper.
(b) Surface potential representation of the
cavity found in the AcpS structures into which
CoA and ACP bind. This figure shows how
CoA fits into the cavity. The dashed line
approximately delineates the boundary
between two AcpS molecules. (c) Details of
the interaction between AcpS, coenzyme A
and solvent. Because the active site of this
enzyme is composed of two molecules of
AcpS those residues that come from one
molecule of AcpS are in red and those from
the second molecule are in blue. The ribbon
diagram was generated with Ribbons [41],
the surface potential with GRASP [42], and
the distance diagram with ChemDraw
CambridgeSoft Corp, Cambridge, MA.
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Structure
atoms and 19 chloride ions. The core of the protein is an α
helix (α4), composed of residues 43–64, that runs the entire
length of the protein. One side of this helix is covered by an
antiparallel β sheet (A-sheet) with topology β1, β5 and β4. A
β ribbon composed of strands β3 and β2, along with α3 com-
bines to cover another side of helix α4. The encasement of
α4 is completed by α1, α2 and a loop consisting of residues
66–75. The fold of this family of proteins is novel, as previ-
ously reported [22]. The Cα atoms of the six AcpS mol-
ecules in the asymmetric unit can be superimposed with a
root mean square difference (rmsd) of 0.497 Å. This align-
ment is improved to 0.168 Å when three mobile loops
(15–24, 80–88, 91–99), the positioning of which differs due
to contacts with symmetry-related molecules, are omitted.
In monomers 2 and 4, the glycine preceding the His6-tag is
observed but the remainder of the His6-tag is disordered.
The electron density for monomers 2–5 ends at residue 118,
whereas that for monomer 1 extends to residue 119 and that
for monomer 6 is traceable to residue 120. 
Based on the structure of Sfp, Reuter and colleagues [22]
postulated that the short-chain P-pant transferases such as
AcpS would fold in a similar manner to one half of the Sfp
protein, and that they would dimerize in a fashion sug-
gested by the two domains of Sfp. This model was accu-
rate but what was not envisioned was that the AcpS
molecules would pack as a trimer, as we show here. Where
the Sfp protein has a C-terminal extension that closes off
the face opposite the two β sheets, the short-chain P-pant
transferases use a third protein molecule. The formation of
this trimer buries the 527  3 surface of the A-sheet from
each AcpS molecule. Each A-sheet is composed of 27
amino acids. For each molecule of AcpS, the sidechains of
15 residues point in towards the middle of the barrel—six
of these residues are hydrophobic. Examination of the face
of each β sheet shows that these six hydrophobic residues
are located on strands β1 and β5 that are located in the
center and to one side of each β sheet. The sidechains
from the third strand, β4, that are directed towards the
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Figure 3
Sequence and secondary structure elements
for AcpS and ACP. Ribbon diagram with the
secondary structure elements labeled for
(a) one AcpS molecule and (b) an ACP
molecule. (c) Sequence alignment of 12
AcpS-type P-pant transferases. The
conserved residues are shown in red. The
secondary structure assignments for
B. subtilis AcpS are shown above the
sequences: helices are shown as rectangles
and β strands as arrows. The last 56 residues
of Thermotoga maritima were omitted as they
have no counterpart in the other enzymes. The
SWISS-PROT accession numbers are given
in the second column for each protein.
(d) The sequence of B. subtilis ACP with the
secondary structure elements shown above.
The conserved serine to which the P-pant
moiety is transferred is shown in red. The
ribbon diagrams were generated with Ribbons
[41] and the sequence alignment was
generated using Microsoft Word.
AcpS
Bacillus subtilis P96618 1 -MIYGIGLDITELKRIAS-MAGRQKRFAERILTRSELDQYY--ELSEKRKNEFLAGRFAAKEAFSKAFGTG
Escherichia coli P24224 1 MAILGLGTDIVEIARIEAVIARSGDRLARRVLSDNEWAIWK---THHQPV-RFLAKRFAVKEAAAKAFGTG
Aquifex aeolicus O66995 1 ----MIGVDIVKNERIKDALERFGDKFLDRIYTKRELEYCY----AHCDFLPCLAARWAGKEAVLKAFYTE
Chlamydophila pneumoniae Q9Z8M5 1 MEIIHIGTDIIEISRIREAIATHGNRLLNRIFTEAEQKYCL----EKTDPIPSFAGRFAGKEAVAKALGTG
Helicobacter pylori O25488 1 ----MIGIDIVSIARIEKCVKRFKMKFLERFLSPSEIVLCK----DKSS---SIAGFFALKEACSKALQVG
Streptomyces coelicolor O86785 1 MSIIGVGIDVAEVERFGA-ALERTPALAGRLFLESELLLP----GGERRGVASLAARFAAKEALAKALGAP
Treponema pallidum O83800 1 -MIIGVGIDIVEIERFVS-WTHNVRLLR-RFFHQEEIVDF----FKNHMRAQFLATRFAAKEAFGKALGTG
Staphylococcus aureus Q9ZAH6 1 -MIHGIGVDLIEIDRIQALYSKQ-PKLVERILTKNEQHKFNN-FTHEQRKIEFLAGRFATKEAFSKALGTG
Thermotoga maritima Q9WZF6 1 -MIVGVGIDVLEVERVP-------EKFAERILGESEKRLF---LTRKRRR-EFIAGRFALKEAFFKALGTG
Rickettsia prowazekii Q9ZCX5 1 -MLIGVGTDIVQIPRIEKILNIYQELFAKKILALKELKQFT--LLNKTNHATFLAKRFSAKEAVSKAFGVG
Bradyrhizobium japonicum O69159 1 -MIIGIGSDLIDITRVGKVIERHGERFLDRIFTAAERAKAERRAKNEKMVVATYAKRFAAKEACSKALGTG
Mycobacterium leprae Q9X7E3 1 MGIVGVGIDLVSIPDFAEQVSQPGTVFM-TIFTPGERRDAS---VKSSSAVCHLAARWAVKEAVIKAWSGS
Bacillus subtilis 68 IGRQL------SFQDIEIRKDQNGKPYIICT--------KLSQA----AVHVSITHTKEYAAAQVVIERLSS
Escherichia coli 65 IRNGL------AFNQFEVFNDELGKPRLRLWGEALKLAEKLGVA----NMHVTLADERHYACATVIIES
Aquifex aeolicus 64 FKIFL------RFKEIEILGNRGRPPTVVINRE--GVEEILKNY----EVIVSLSHERDYSVAVAYIKKKS
Chlamydophila pneumoniae 68 IGSVV------AWKDIEVFKVSHGPEVLLPS----HVYAKIGIS----KVILSISHCKEYATATAIALA
Helicobacter pylori 61 IGKEL------SFLDIKISKSPKNAPLITLSK---EKMDYFNIQ----SLSASISHDAGFAIAVVVVSSSNE
Streptomyces coelicolor 69 AG--L------LWTDAEVWVEAGGRPRLRVTGTVAARAAELGVA----SWHVSLSHDAGIASAVVIAEG
Treponema pallidum 60 LRN-M------ELRNIRVCQNGWGKPRLEVYGAAQAMLAATGGT----HIQVSLTHEREVASAIVIIEGEPL
Staphylococcus aureus 69 LGKHV------AFNDIDCYNDELGKPKI----------DYEGF-----IVHVSISHTEHYAMSQVVLEKSAF
Thermotoga maritima 67 LNGH-------SFTDVEFLESN-GKPVLCVH------KDFGFFN----YAHVSLSH-DRFAVALVVLEKRKG
Rickettsia prowazekii 68 IGRGI------NFKDITILNDNLGKPTVEISS---HYTNKLAPF----NIHLSLSDDYPICIAFAIIESNC
Bradyrhizobium japonicum 71 IRRGV------WWRDMGVVNLPGGRPTMQLTGGALARLQALTPDGFEARIDVSITDDWPLAQAFVIISAVPLAKS
Mycobacterium leprae 68 RFAQRPMLPENIHRDIEVVNDMWGRPRVRLTG---AIAKHLTDV----TIHVSLTHEGDIAAAVVILEVL
ACP
Bacillus subtilis P80643 1 ADTLERVTKIIVDRLGVDEADVKLEASFKEDLGADSLDVVELVMELEDEFDMEISDEDAEKIATVGDAVNYIQNQQ
b 1 a1 a2 a3 a4
b2 b3 b4
b5
a1 a2 a4 a5a3
Structure
(a)
(c)
(b)
center of the barrel are all hydrophilic (His100, Ser102,
Thr104 and Thr106). The sidechains of these β sheets that
are directed away from the center of the barrel possess an
electronic nature that compliments those pointing into the
barrel; those residues from strand β4 that are pointing
away from the barrel are composed mostly of hydrophobic
residues while those from strand β1 are composed mostly
of hydrophilic residues. This differentiation in hydrogen-
bonding ability undoubtedly aids in the orientation and
packing of the AcpS molecules to form the active oligomer
as the polar sidechains on strand β4 interact with the polar
side of strand β1 from a second AcpS molecule. The inter-
face, where the β sheets of two AcpS molecules intersect
in the trimer, is therefore polar. The area above this inter-
section is open to solvent and is at the bottom of a bowl-
shaped depression in the surface of the protein assembly.
In this structure, the three bowl-shaped depressions are
filled with numerous water molecules as well as three chlo-
ride ions and one sodium ion. An enzymatic active site is
located inside each depression. One half of each active site
comes from one molecule of AcpS and the other half from
a second AcpS molecule in the trimer. Examination of a
surface representation of this depression (Figure 2) shows
that it has distinct regions of positive and negative electro-
static potential to aid in cofactor and substrate binding.
Aside from the packing of the β sheets, the only other
interactions (both van der Waals and ionic) between the
three molecules in the trimer occur between residues of
two loops consisting of residues 65–67 from one AcpS mol-
ecule and residues 84–86 from a second AcpS molecule.
The structure of the AcpS trimer was searched against a
database of known structures using DALI [26] and the
results indicated that there are no known structures with
the nine-stranded threefold symmetric pseudo β-barrel
motif observed in this oligomer.
The structure of AcpS and CoA 
The final model of AcpS–CoA in the rhombohedral crystal
contains residues 1–118 of one molecule of AcpS, one
molecule of CoA, 99 solvent molecules, two calcium
atoms, and one chloride ion. Similar to the AcpS structure
described above, the electron density extends to residue
118 and there are no breaks in the density between
residues 1–118. The binding of CoA does not result in any
changes in the secondary structure of the protein and the
same trimeric arrangement of the protein molecules
described in the P21 space group above is also present in
this structure (Figure 2). The monomer of AcpS in this
structure of the AcpS–CoA complex is positioned such
that the molecular threefold axis of the trimer is coinci-
dent with a crystallographic threefold axis. 
Inside the bowl-shaped depression described above, CoA
fits into a groove along the anionic ridge between the
A-sheets of two AcpS molecules. The adenine ring of CoA
(Figure 2) fits into a pocket formed by a loop consisting of
residues 80–88 and residues 62–70 from a symmetry-
related molecule. As observed in the structure of CoA
bound to Sfp [22], the ribose is present in the 3′-endo con-
formation that has the 2′-hydroxyl placed axially and the
3′-phosphate in an equatorial position. The 3′-phosphate
of CoA is held in place by the protein through hydrogen
bonds provided by the sidechains of Arg53 and His105
(Figure 2). The interactions between the pantetheine arm
and the protein are predominately van der Waals. The
β-mercaptoethylamine segment rests in a shallow
hydrophobic pocket formed on the surface of the protein
by the aliphatic portion of the sidechains of Arg28, Met18,
Phe25, Ile29, Phe54 and Phe74. The β-phosphate from
the pyrophosphate moiety of CoA has no direct contact
with the protein and the α-phosphate is within hydrogen-
bonding distance of the mainchain amide of His105 and
the ζ-amino group of Lys62. The interactions described
here create a mode of binding for the CoA where the pan-
tetheinyl arm extends away from the adenine base
(Figure 2). In contrast, the mode of CoA binding in other
protein–CoA complexes, such as the human PCAF tran-
scriptional regulator [27], has the pantetheinyl arm
bending back toward the adenine base.
The α-phosphate from CoA, along with Glu58 and Asp8
from AcpS, are involved in the coordination of a metal ion;
the coordination sphere is completed by three water mol-
ecules. This cation is normally magnesium [28] but the
bond lengths between this metal ion and its ligands
suggest that in this crystal the divalent cation is calcium.
This is consistent with the conditions used to obtain these
crystals, which have 100 times more calcium than magne-
sium. We have found (data not shown) that when the
protein is subjected to extensive dialysis to remove mag-
nesium and the activity of the enzyme is measured in the
presence of calcium, transfer of the P-pant group to ACP
still occurs although at a reduced rate.
Sequence alignment of the P-pant transferase family
(Figure 3) identified a number of conserved residues
[19–22]. In this structure, these residues (Gly6, Asp8,
Phe54, Lys57, Glu58, Ala59, Lys62) are all located in the
bowl-shaped depression created by two AcpS molecules as
described above. This crystal structure of CoA complexed
to AcpS allows us to assign a function to these conserved
residues. As mentioned above, Asp8 and Glu58 are essen-
tial as they both chelate the magnesium ion. Phe54 partici-
pates in creating a hydrophobic pocket for the
panthetheine arm to rest in as well as restricting the rota-
tional isomers available to the sidechain of Glu58. The
mobility of Phe54 is restricted by the location of Lys57 and
this residue is held in place via a salt bridge with Glu34.
Glu34 was not identified as conserved by Lambalot or
Reuter but Figure 3 shows that it is conserved in at least a
subset of this family. One of the more intriguing residues
in this short list of highly conserved residues is Lys62. This
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lies in an extended conformation pointing towards the
pyrophosphate moiety of the CoA. It is within hydrogen-
bonding distance of the α-phosphate and also Asp8. This
positioning suggests a mechanistic role that will be dis-
cussed later. As reported by Reuter, the requirement for
residues with small sidechains at residues 6 and 59 is owing
to spatial considerations. A small sidechain is required at
residue 6 as a larger sidechain would interfere with the
placement of Lys62 and Ser102. Likewise, a larger
sidechain at residue 59 would interfere with the packing
between helix α4 and strands β1 and β5 of the A-sheet.
The structures of AcpS and holo-ACP
The final model of AcpS–ACP contains residues 2–118 of
AcpS, residues 1–73 of holo-ACP and 117 solvent mol-
ecules. The contacts between holo-ACP and AcpS are pre-
dominately hydrophilic in nature with almost all of the
interactions occurring between helix α1 of AcpS and helix
α3 of ACP (Figure 4). There are only two significant
hydrophobic contacts and these both involve residues
from ACP (Leu37 and Met44) that protrude into
hydrophobic pockets on AcpS. Leu37 extends into a
pocket formed by Met18, Phe25, Phe54 and Ile15 on
AcpS, whereas Met44 binds in a pocket formed by Phe25
and the aliphatic portion of the sidechains from Arg28 and
Gln22. These interactions are summarized in Table 3.
Examination of this structure suggests that a key residue
in the binding of ACP to AcpS is Arg14 from AcpS. Arg14
forms a salt bridge with the residue just before the reac-
tive serine (Asp35) of ACP and is involved in hydrogen
bonding with Asp38, two residues after the reactive
serine. These interactions serve to position the ACP mol-
ecule so that one end of helix α3 from ACP is placed at
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Figure 4
Stereoviews detailing the interaction of ACP and AcpS. (a) Ribbon
diagram showing ACP bound in each active site of the AcpS trimer.
(b) View of the interaction between helix α3 of ACP and helix α1 of
AcpS. (c) When the AcpS molecules as found in the complex
structure with CoA are superimposed with the coordinates of AcpS as
found in the complex structure with ACP, it is possible to generate a
model of AcpS (red and yellow), ACP (light blue) and CoA (dark blue)
all binding at the same time. In this illustration the dipole of helix α3
points at the pyrophosphate moiety of CoA placing Ser36 near the
β-phosphate and adjacent to a water molecule (Wat2). The
conformation of the P-pant group after attachment to Ser36 is shown
as a thin gray line. The figure was generated with Ribbons [41].
the bottom of the active site and correctly orients Ser36.
As shown in Figure 3, Arg14 is conserved in all AcpS pro-
teins, except that from Mycobacterium in which it is an
aspartic acid. Another arginine residue, Arg21, of AcpS
forms a salt bridge with Glu41 from ACP. The other end
of helix α3 is positioned by the interactions of Arg24 and
Gln22 from AcpS with Asp48 of ACP. These interactions,
along with the two hydrophobic ‘keys’ described above,
lock the α3 helix of ACP into place. 
When the structure of AcpS–CoA and AcpS–ACP are
superimposed it is evident that a loop consisting of
residues 64–78 enlarges the active site by shifting 2 Å to
accommodate helix α4 from ACP. Additionally, this super-
imposition of the structures allows for the construction of a
model depicting the interaction between AcpS, ACP and
CoA (Figure 4). From this model, it can be seen that the
dipole of the α2 helix of ACP is directed at the phosphate
of the CoA that is to be transferred to ACP. 
Mutational analysis of the trimerization domain
To address the question of whether or not the trimer is a
physiologically relevant form of AcpS, we carried out muta-
tional studies. As mentioned previously, the driving force
of the trimer formation seems to be burying the large
hydrophobic surface of the A-sheet. The three N termini of
the trimer are located on one end of the β barrel and these
termini contain a conserved motif ([V/I]G[V/I]D[V/I]; in
single-letter amino acid code) that is found in almost all of
the currently known P-pant transferases [19]. This con-
served stretch forms the first β strand, β1, which packs
against β4 and β5 from another molecule in the trimer. Not
surprisingly, the residues exposed towards the interior of
this β barrel are largely hydrophobic. One of these residues,
Ile5, makes extensive contacts with residues His100,
Val101, Ser102, Val115, Val114 and Gln113 of the neigh-
boring molecule. In addition, the residue in the center of
strand β5, Gln113, is the only polar residue buried in the
interior of the β barrel, and it makes a tight hydrogen-
bonding network with the Gln113 residues from the other
two molecules in the trimer. Because neither of these
amino acids are directly involved in CoA or ACP binding,
any effect of the mutation on AcpS activity was expected to
be largely due to the packing of the trimer. Additionally,
modeling showed that two molecules of the mutant AcpS
would still be able to form a viable active site but that for-
mation of the trimer would be hindered. The location of
residues 2, 5 and 113 with respect to the trimerization inter-
face can be seen in Figure 2.
The mutation Gln113→Glu results in a substitution
where the sidechain is of similar size but possesses a
different hydrogen-bonding capacity. Additionally, a
Gln113→Arg substitution was prepared so that both the
size and the polarity of the sidechain were altered. We
hypothesized that a non-conservative change such as
Ile5→Arg would be necessary to disrupt the stable trimer
structure. Finally, the AcpS construct used for obtaining
the ACP–AcpS complex structure contains an Ile2→Ala
mutation. Because this mutation resulted in a protein with
a different retention time on the gel-filtration column, we
decided to further characterize its activity.
The Ile2→Ala, Gln113→Glu, Gln113→Arg and Ile5→Arg
mutant proteins were expressed in E. coli as soluble pro-
teins. Except for the Ile2→Ala mutant, each showed a
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Figure 5
Activity measurements of wild-type (s) and mutants of AcpS.
Gln113→Glu,  Ile2→Ala, × Gln113→Arg, u  Ile5→Arg, n  and no
enzyme control, ∨. [1–14C]acetyl P-pant transfer assays were carried out
by incubating 2 µM apo-ACP and 2 nM AcpS in 50 mM Tris-Cl pH 8.5,
200 mM NaCl, 10 mM MgCl2 and 100 µM acetyl CoA at 37°C [21,29]. 
  
 

 











 


Table 3
Hydrophilic interactions between ACP and AcpS.
ACP residue AcpS residue Distance (Å)
Asp35 OD1 Arg214 NH2 2.8
Asp35 OD2 Arg214 NH1 2.5
Asp35 OD2 Arg214 NH2 3.0
Asp38 OD1 Arg214 NH2 3.0
Asp38 OD2 Arg214 NH2 3.2
Glu41 OE1 Arg221 NH2 2.7
Glu41 OE2 Arg221 NE 2.9
Asp48 OD1 Arg224 NH1 2.9
Ile54 O   Arg228 NH2 2.6
Asp56 OD2 Ser273 OG 2.5
Asp56 OD2 Phe274 N 2.8
Glu60 OE2 Ala270 N 3.0
reduced expression level when compared with the wild-
type enzyme with the lowest level of expression observed
for the Ile5→Arg mutant. We purified the mutant proteins
to near homogeneity, as judged by SDS–PAGE. All of the
mutants showed similar behavior to the wild-type enzyme
on the ion-exchange column. The His6-tag that was a part
of the Gln113→Glu, Gln113→Arg and Ile5→Arg mutants
facilitated the separation of the recombinant proteins from
the endogenous E. coli AcpS. 
The effects of these mutations on AcpS activity were
investigated by measuring the AcpS catalyzed attachment
of a 14C-labeled acetyl-P-pant group onto apo-ACP. As
shown in Figure 5, the wild-type enzyme showed an
initial velocity of 30 min–1, at an ACP concentration of
2 µM and a CoA concentration of 100 µM. This is compa-
rable with previous observations for the E. coli AcpS
[21,29]. The effect of the mutation at position 113 was
highly sensitive to the nature of the substituted amino
acid. The initial velocity for the Gln113→Glu mutation
was  approximately sevenfold slower than the wild-type
enzyme, whereas the Gln113→Arg mutant was com-
pletely inactive. The Ile5→Arg mutant also proved to be
inactive. Surprisingly, the Ile2→Ala mutant retained only
6% of the wild-type activity, even though the mutation is
at the very N terminus of the polypeptide chain. 
For the purpose of observing whether mutations hindered
trimer formation, we measured their relative
molecular weights as determined by mobility on a size-
exclusion column under native conditions (Table 4). From
the size-exclusion data, the mutants fall into two cate-
gories; those that are consistent with a trimer (wild-type-
like) and those with apparently reduced molecular weight.
All mutants with reduced molecular weight have no mea-
surable activity suggesting one of three possibilities: that
the trimer is necessary for activity; that the mutations have
disrupted the structure of the protein around the active
site; or that these single-point mutations have produced
misfolded proteins. This last scenario seems unlikely as all
of the mutant proteins have the same retention time on
ion exchange columns. Furthermore, isotopically labeled
Ile2→Ala AcpS was purified and its high-resolution NMR
spectra indicated that it has a well-defined tertiary struc-
ture (GY Xu, unpublished observations). The reduced
molecular weights of these mutants suggest that the wild-
type trimer is the only catalytically competent form. The
molecular weight of Gln113→Glu mutant is consistent
with a trimer at the high concentrations used in the size-
exclusion experiment. The fact that it retained some
activity and its high molecular weight suggests the possi-
bility of an alternate hydrogen-bonding network for
Glu113 that allows for the formation of the trimer. This
mutation could be interpreted as shifting the equilibrium
away from the active trimer, resulting in reduced activity.
The final mutation, Ile2→Ala, could also be interpreted in
the same way, although its proximity to Asp8, one of the
ligands to the metal in the active site, does not exclude
local structural perturbation as a mode of inhibition.
Reaction mechanism
As expected, examination of the hydrogen-bonding pattern
in the AcpS–CoA structure suggests that the ζ-amino group
of Lys62 has been protonated and that Asp8 has been
deprotonated. It is possible that the hydrogen on Asp8 was
transferred to Lys62 as they are spacially adjacent. It is
tempting to speculate that one of three water molecules
(Wat2) bound to the calcium is an ‘activated’ water owing
to the short distance between it and the pyrophosphate 
β-phosphate. The formation of this metal-bound activated
water would be in agreement with the known mechanism
of other metalloenzymes in which water is utilized [30,31]. 
It has been suggested [22] that during the mechanistic
event, it would be possible for the hydroxyl of Ser36 to
replace this water molecule and be deprotonated prior to
nucleophilic attack on the pyrophosphate. These struc-
tures suggest that an alternative mechanism would have
the metal-bound water removing the hydroxyl hydrogen
from Ser36. Examining the model of the ternary
complex suggested by these structures (Figure 4) shows
that with the ACP bound as shown in the ACP–AcpS
costructure, a rotation of the Cα–Cβ bond would place
the hydroxyl hydrogen adjacent to Wat2. Wat2 would
then remove this hydrogen and prepare Ser36 for nucle-
ophilic attack on the phosphate. Utilizing this mecha-
nism, it is conceivable that, in the absence of substrate,
the metal-bound hydroxide would be able to activate a
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Table 4
Gel-filtration chromatography† to estimate the apparent
molecular weight of ACPS mutants.
Retention time (min) Apparent MW (kDa)
Standard
Ovalbumin 16.4 44
Myoglobin 22.5 17
AcpS*
Wild-type (His-tagged) 16.9 42
Gln113→Glu 16.5 44
Gln113→Arg 18.6 34
Ile5Arg 18.6 34
Wild-type (no tag) 17.2 41
Ile2→Ala 18.1 37
*The theoretical molecular weight of AcpS His-tagged and non His-
tagged monomers are 14.8 kDa and 13.7 kDa, respectively, which
are equivalent to a trimer of 44.4 kDa and 41.1 kDa. †AcpS was
loaded onto a Tosohass G2000SWXL column with 50 mM NaOAc
pH 4.6, 0.5 M NaCl, 10 mM MgCl2 and 10 mM DTT as running
buffer. These conditions were chosen because of the higher
solubility of the enzyme at acidic pH. The retention time difference
between the mutants and the wild-type enzyme at pH 4.6 is similar to
that at lower enzyme concentration and neutral pH.
water molecule for nucleophilic attack of the β-phos-
phate of the CoA pyrophosphate. The data for the
AcpS–CoA structure tends to support this hypothesis as
the electron density observed for the β-phosphate
(Figure 1) was seen to not properly fit the tetrahedral
phosphorous placed there. If this four-coordinate tetra-
hedral phosphorous was replaced with a five-coordinate
trigonal bi-pyramidal phosphorous it would also fit the
electron density. The original MAD electron-density
map and an omit map calculated for this region suggest
that the best model for the β-pyrophosphate in this
structure is for the CoA to be present with both a four-
coordinate and a five-coordinate phosphorous. 
These observations suggest a catalytic mechanism for the
enzyme (Figure 6). First, Wat2 is activated by the removal
of a proton. This proton could be removed by another
water molecule or by Asp35 of ACP, which is spatially
adjacent. Wat2 removes the hydroxyl hydrogen from
Ser36 of ACP, which then carries out the nucleophilic
attack on the β-phosphate of CoA. This results in the
transfer of the P-pant group to Ser36, and the resulting
negatively charged 3′,5′-ADP is stabilized by interactions
with magnesium, Lys62 and the His105 mainchain amide.
A proton can then be transferred to 3′,5′-ADP from either
solvent or Lys62, followed by dissociation of the products.
This mechanism suggests that in the absence of ACP it
would be possible for AcpS to catalyze the hydrolysis of
CoA to 3′,5′-ADPP and phosphopantetheine. Because we
observed the intact CoA moiety in the crystal structure,
the equilibrium seems to favor intact CoA. Clearly, when
ACP binds the equilibrium changes, resulting in the trans-
fer of the P-pant group to ACP.
A proposed order of binding explains substrate inhibition
Preliminary studies using both gel-filtration chromato-
graphy and analytical ultracentrifugation (data not
shown) on the Ile2→Ala mutant indicate an increase of
the molecular weight to a trimer upon the addition of
CoA. These results as well as those of prior studies
[29–32] suggest that the binding of CoA to initiate the
formation of a tighter protein assembly is the first event
to occur. Once CoA and magnesium have bound to AcpS,
the binding of ACP will initiate the P-pant transfer. This
is supported by the structure as CoA bridges two
monomers (Figure 2). After binding CoA, the electrosta-
tic potentials of the binding site have changed and as
ACP binds, the dipole of the ACP α3 helix is directed
toward the β-phosphate of the pyrophosphate. Once the
P-pant group has been transferred to ACP, the bridging
and trimer stabilization function of CoA is lost. The fact
that the charged phosphate that promoted ACP binding
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Figure 6
The mechanism that can be derived from the
crystal structures in this study. The metal-
bound water molecule removes the hydrogen
from Ser36, converting it into a nucleophile
and thereby initiating P-pant transfer and
activation of ACP.















































































































ACP
Ser36
ACP
Ser36
ACP
Ser36
ACP
Ser36
Structure
to AcpS has now been transferred to ACP and the loss of
the stability afforded to the trimer by CoA combine to
facilitate the release of holo-ACP.
The ternary complex shown in Figure 4 does not have suf-
ficient room for a CoA molecule to enter the active site if
ACP binds first, so in such a case, the ACP–AcpS complex
would be unproductive. This observation and hypothesis
of the order of binding provides an explanation for the
observation [29] that apo-ACP can be an inhibitor at higher
concentrations. The model derived from these crystal
structures suggests that 3′,5′-ADP would not be released
until after the release of holo-ACP. It can be envisioned
that if the concentration of ACP is high enough, it would
be possible to trap the 3′,5′-ADP in the active site before it
dissociates, again generating an unproductive complex.
Biological implications
Phosphopantetheinyl (P-pant) transferases are essential
in the initiation of the biosynthesis of fatty acids, poly-
ketide antibiotics and non-ribosomal peptides. Their func-
tion is to convert the apo-form of a carrier protein to the
active holo-form by the post-translational introduction of
a reactive thiol that is attached to the end of a long pros-
thetic group. This prosthetic group, the phosphopant-
etheinyl moiety of coenzyme A, is attached via a
phosphodiester linkage to the hydroxymethyl sidechain of
a conserved serine residue on the carrier protein. Each
carrier protein has a corresponding P-pant transferase
that has been optimized for its activation. Prior biochemi-
cal studies [19–34] have demonstrated that the
Escherichia coli P-pant transferase is capable of modify-
ing the apo-forms of several type II acyl carrier protein
(ACP) homologs but shows no detectable activity
towards type I P-pant-requiring proteins. Type I P-pant
transferase proteins, such as Sfp and EntD, are not only
active towards their type I substrates but also transfer the
P-pant group onto type II apo-ACP, although only very
weakly in the case of EntD [19]. This unidirectional
cross-modification at first seems confusing but comparing
the structure of acyl carrier protein synthase (AcpS)
(subgroup II) with the structure of Sfp (subgroup I)
affords an explanation. Examination of the superimposed
structures show that the active site for Sfp is both more
shallow and wider than the active site of holo-AcpS. This
correlates well with the sizes of their substrates because
the type I substrates are usually a domain of a much
larger multifunctional protein. This domain can easily fit
into the active site of a P-pant transferase that has a large
and shallow active site such as that found in Sfp. When
this domain is a part of a large protein, it cannot fit into
the deep and narrow active site of a short chain P-pant
transferase such as AcpS. By contrast, the smaller ACP
can easily fit into the active site of AcpS as well as into
the active site of Sfp-type enzymes. Modeling the ACP
structure described in this article in complex with the Sfp
structure from the Protein Data Bank (accession code
1QR0) shows the fit is not optimal and that the P-pant
transfer should be less efficient. 
Materials and methods
Expression and purification of AcpS and SeMet–AcpS 
B. subtilis AcpS, cloned into pBAD/HIS, was expressed in DH10B
E. coli. Cells were lysed in a buffer containing 50 mM HEPES-Cl,
pH 7.4, 250 mM NaCl, 10 mM MgCl2 and 10 mM DTT. AcpS in the
soluble extract was purified on a Poros PI, Poros HS at pH 8.0, Poros
HS at pH 4.5 (all from PerSeptive Biosystems, Framingham, MA), and
gel-filtration chromatography steps similar to the conditions used for
E. coli AcpS (Lambalot, 1995, Flugel, 2000). SeMet–AcpS was puri-
fied using the same procedure.
Expression and purification of ACP
B. subtilis ACP was cloned into the pGEX-6P-1 vector and expressed
in E. coli strain BL21DE3 (pLysS). Cells were lysed in a buffer contain-
ing 50 mM Tris-Cl (pH 8.0), 300 mM NaCl, 10 mM MgCl2 and 2 mM
MnCl2 [35]. The GST–ACP fusion protein was purified on a glutathione
sepharose column (Amersham Pharmacia Biotech, Piscataway, NJ) and
cleaved with Precission Protease (Amersham). ACP was purified on a
MonoQ HR16/10 column (Amersham) with a NaCl gradient. 
Crystallization of AcpS
Prior to crystallization, the protein was dialyzed against a solution con-
taining 10 mM sodium acetate pH 4.4, 2 mM MgCl2, 100 mM NaCl,
5 mM DTT and then concentrated to ~10 mg/ml according to the
Bradford method [36]. Diffraction-quality plate-like crystals were
obtained at 18°C from 2.5 M NaCl, 0.1 M Tris pH 7.0 and 0.2 M
MgCl2. These crystals belonged to space group P21 with cell dimen-
sions of a = 76.26 Å, b = 76.16 Å, c = 85.69 Å, β = 93.3° and con-
tained six molecules of AcpS in the asymmetric unit. The
SeMet–AcpS also crystallized using these conditions with the excep-
tion that the concentration of DTT was increased to 10mM to help
protect against oxidation of the selenium atoms.
Crystallization of AcpS with CoA
The protein solution was prepared as above with the exception that 24 h
before crystallization screening, 1 mM CoA (di-sodium salt, Fluka) was
added. Diffraction quality CoA–AcpS co-crystals were obtained at 18°C
from 0.2 M CaCl2 and 20% PEG 3350. These crystals belonged to
space group R3 with cell dimensions a = b = 55.82 Å, c = 92.28 Å and
contained one molecule of AcpS and one molecule of CoA in the asym-
metric unit. The SeMet AcpS–CoA crystallized under the same condi-
tions with the exception that the concentration of DTT was increased to
10 mM to help protect against oxidation of the selenium atoms.
Crystallization of AcpS with holo-ACP
Purified holo-ACP and AcpS were mixed at a 1:1.1 molar ratio and
purified using a gel filtration column. The resulting purified complex was
dialyzed against a solution containing 50 mM Bis-Tris pH 6.4, 100 mM
NaCl, 10 mM MgCl2, and 10 mM DTT before concentrating the
complex to ~10 mg/ml. Crystals were grown from between 0.15 M and
0.3 M potassium formate and between 15 and 23% PEG 3350. These
crystals belonged to space group C2221 with unit cell parameters
a = 78.46, b = 122.03, c = 136.77 Å and contained three molecules of
AcpS and three molecules of ACP in the asymmetric unit. 
Data collection: native
Single-wavelength (1.2 Å) data for the native AcpS and AcpS–CoA crys-
tals were collected on beamline 5.0.2 at the ALS, Berkeley using an
ADSC Quantum-4 CCD detector. A single crystal, cooled to –180°C,
was used for each data set. The data were processed using DENZO and
Scalepack [37] and the statistics from refinement are given in Table 2.
Data from the ACP–AcpS complex crystals were collected using a R-Axis
IV mounted on a Rigaku RUH2R rotating anode operating at 5 kW from a
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single crystal, cooled to –180°C. The oscillation images were processed
as described above with the statistics also reported in Table 1.
Data collection: MAD 
During the same trip, MAD data were collected on beamline X12-C at the
NSLS (Brookhaven National Laboratory, Upton, NY) from a single crystal
of SeMet–AcpS, P21 form and from a single crystal of the SeMet-
AcpS–CoA complex, R3 form. Each crystal was cooled to –180°C for
data collection as described above. The wavelengths used can be found
in Table 1. These data were then used as input to the program SOLVE
[38] for local scaling of the datasets of the Selenium atom positions.
Heavy atom parameters for each were refined with SHARP [39].
Model building and refinement: AcpS
The structure of the AcpS monoclinic form was built into the original
2.5 Å resolution solvent-flattened symmetry-averaged MAD map using
the X-AUTOFIT features within QUANTA (Molecular Simulations Inc.,
San Diego, CA). The phases were then extended from 2.5–2.2 Å with
symmetry averaging in DM. This model was then used as the initial
model for refinement using the program CNS [40] against the native
data, which extended to 1.8 Å. Prior to refinement, 5% of the data were
randomly selected and designated as a Rfree test set to monitor the
progress of the refinement. Following seven cycles of refining and
rebuilding the refinement converged with a model which contained six
molecules of AcpS, 471 water molecules, eight sodium ions, 19 chlo-
rine ions, five DTT molecules and two glycerol molecules at an Rcryst of
19.6% (Rfree 21.9%). The refinement statistics are given in Table 2.
Model building and refinement: AcpS–CoA
The structure the AcpS–CoA complex was solved using a combina-
tion of molecular replacement and MAD phasing. Monomer 1 of the
monoclinic AcpS structure was utilized as a molecular replacement
probe with AMoRe [24]. The molecular replacement solution was
then rebuilt into a 2.1 Å resolution solvent-averaged MAD map thus
eliminating any bias from the molecular replacement solution. The
structure was refined in CNS using the methods described above.
Refinement converged after six rebuilding cycles with a Rcryst of
18.5% and a Rfree of 20.1%. The final model consisted of residues
1–118, CoA, 99 waters, two calcium ions and one chloride ion. The
refinement statistics are given in Table 2. 
Model building and refinement: AcpS–holo-ACP
The complex between holo-ACP and AcpS was generated from protein
purified by gel filtration thus generating a stoichiometric ratio. Crystals
of this complex diffract to 2.3 Å using an R-Axis IV mounted on a Rigaku
RUH2R rotating anode operating at 5 kW. The structure of the
ACP–AcpS complex was solved by molecular replacement using the
program AMoRe [24], with the trimer of AcpS as found in the
AcpS–CoA structure as the probe. Prior to refinement, 10% of the data
were randomly selected and designated as a Rfree test set to monitor
the progress of the refinement. The structure of the AcpS trimer was
then rebuilt within QUANTA utilizing a series of omit maps. During this
rebuilding, extra density was found in each active site that sharpened
after each cycle of rebuilding. When the AcpS molecules had been
rebuilt, the NMR structure of the B. subtilis ACP (Guang-Yi Xu, manu-
script in preparation) was rotated into the density found in the active
site. As a result of a large domain shift, a consequence of binding to
AcpS, there were enough differences between the NMR structure and
the X-ray data to preclude using the NMR model as the starting point
for refinement. Instead, the location of Met44 was noted from the NMR
structure and the remainder of the ACP molecule was built into density
using omit maps from that residue. Reference to the NMR structure as
a source of secondary structure information allowed the structure of the
three ACP molecules to be built into the electron density rapidly.
When roughly 80% of the ACP had been built into density, that
ACP–AcpS model was then used as the initial model for refinement
using CNS. Following six cycles of refining and rebuilding the refinement
converged with a model that contained three molecules of AcpS, three
molecules of AcpS and 117 solvent molecules at an Rcryst of 22.2% and
Rfree of 27.9%. The refinement statistics are shown in Table 2.
Accession numbers
The coordinates for the three structures described in this paper have
been deposited in the PDB. The PDB ID codes are 1F7T for the AcpS
structure, 1F7L for the AcpS–CoA structure and 1F80 for the
AcpS–holo-ACP structure. 
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